This ATPA fact sheet explains the current knowledge about cardiovascular (heart) disease risk in people living with HIV/AIDS, and some strategies for minimising risk.
Staying well
Recent advances in HIV treatments mean that people living with HIV are leading longer and more productive lives. But short and long-term side effects remain a major concern for positive people and for NAPWA.
NAPWA’s Health & Treatments Portfolio works with pharmaceutical companies, educators, clinicians and government to ensure we have access to the best treatments and information possible. Our HIV Health & Treatments Project is also active in this area, actively representing the interests of positive people in many ways.
The AIDS Treatment Project Australia (ATPA) develops educational materials and organises the popular Treatments Information Roadshow and Chin Wag events all around Australia.
Abacavir and heart attacks
From the March 2008 issue of Positive Living
Latest results presented by investigators at the CROI meeting in February in Boston suggested that treatment with abacavir (also found in the combination pills Kivexa and Trizivir) and ddI (didanosine, Videx) may significantly increase the risk of myocardial infarction, or heart attack.
Bareback is the new safe sex – or is it?
From the March 2008 issue of Positive Living
The announcement by a group of Swiss AIDS experts that people with undetectable viral load are sexually non-infectious needs to be treated with caution, writes Paul Kidd.
People with HIV need informed, independent advice to make treatment decisions
19 May 2008 - 12:00am
Continuing improvements in HIV treatment are helping many people with HIV lead healthy lives, but some HIV-positive people may not be well-enough informed about the latest treatment options, the National Association of People Living with HIV/AIDS (NAPWA) has said in a statement to mark the launch of an innovative new HIV treatments information project.
Treataware – coming soon
26 March 2008 - 5:53pm
Treataware, a suite of major NAPWA/ATPA treatments intitatives, will be launched in May 2008.
Good news, bad news: report from CROI
From the March 2008 issue of Positive Living
John Daye, NAPWA's Health, Treatments & Research Portfolio Co-Convenor reports from the 15th Conference on Retroviruses and Opportunistic Infections (CROI) held in Boston, USA from 3-6 February 2008
Lipo: any progress?
1 December 2007 - 6:07pm
While newer antiretrovirals do not appear to cause lipoatrophy, the disfiguring side effect characterised by loss of fat from the face and limbs, the problem is still very much with us. David Menadue examins the latest research and treatments.
Beware the Grim (or, how I manage my depression)
1 December 2007 - 6:07pm
Many HIV-positive people struggle with depression. Graham Douglas-Meyer shares his strategies for dealing with this most common form of mental illness.